Medgend Icon







discontinued


Capecitabine FDA Approved Drugs

CAPECITABINE [CapecitabineC15H22FN3O6]
RX
-
150mg (oral tablet)
500mg (oral tablet)
Accord HlthcareApr 23, 2015
Amneal PharmsFeb 28, 2017
Mylan Pharms IncAug 8, 2014
Shilpa Medicare LtdDec 12, 2016
Teva Pharms UsaSep 16, 2013
West-ward Pharms IntJul 14, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

IXEMPRA KIT [IxabepiloneC27H42N2O5S]
RX
-
15mg/vial (iv (infusion) injectable)
45mg/vial (iv (infusion) injectable)
R-pharm Us LlcOct 16, 2007
  • A method of treating cancer in a patient comprising administering ixabepilone or pharmaceutical compositions comprising ixabepilone.
  • Method of treating breast cancer by administering ixabepilone; a method of treating a cancer responsible to microtubule stabilization by administering ixabepilone.
  • Method of treating cancer in a patient comprising intravenously administering to the patient ixabepilone diluted in a parenteral diluent.
  • Method of treating cancer, iv admin, lyophylized ixabepilone diluted, every week or 3 weeks; lyophilized ixabepilone with solvent(dehydrated ethanol) diluted to concentration of 0.1mg/ml to 0.9mg/ml.
  • Method of treating patient comprising mixing first and second vials of product comprising lyophilized ixabepilone to provide an epothilone analog solution, diluting solution with a suitable diluent to prepare intravenous formulation for pt.
  • Use of ixabepilone in combination with capecitabine in treatment of metastasis breast cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VISTOGARD [Uridine TriacetateC15H18N2O9]
RX
-
10gm/packet (oral granule)
Wellstat TherapDec 11, 2015
  • Emergency treatment of adult & pediatric patients following fluorouracil or capecitabine overdose,or who exhibit early-onset,severe or life-threatening cardiac or cns toxicity or unusually severe adverse reactions within 96 hours.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

XELODA [CapecitabineC15H22FN3O6]
RX
-
150mg (oral tablet)
500mg (oral tablet)
Hoffmann La RocheApr 30, 1998
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.